Enhanced adaptive immunity in mice lacking the immunoinhibitory adaptor Hacs1

FASEB Journal

Volumn 24, Issue 3, 2010, Pages 947-956

  Wang, Dingyan ^a,b,c   Stewart, A Keith ^d   Zhuang, Lihua ^c   Zhu, Yuanxiao ^d   Wang, Youdong ^a,b   Shi, Changxin ^d   Keating, Armand ^c   Slutsky, Arthur ^a,b   Zhang, Haibo ^a,b   Wen, Xiao Yan ^a,b,c,e  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c PRINCESS MARGARET HOSPITAL   (Canada)

^d MAYO CLINIC   (United States)

^e TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Adaptor protein; B cells; Dendritic cells; Gene targeting; Immune regulation; SAM domain

Indexed keywords

ADAPTOR PROTEIN; B LYMPHOCYTE RECEPTOR; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; OVALBUMIN; PROTEIN HACS1; PROTEIN KINASE B; PROTEIN KINASE LYN; PROTEIN SH3; UNCLASSIFIED DRUG; TYROSINE; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY PRODUCTION; ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CONTROLLED STUDY; DENDRITIC CELL; ENZYME PHOSPHORYLATION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; KNOCKOUT MOUSE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PERITONEUM CELL; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; ANIMAL; BACTERIAL ARTIFICIAL CHROMOSOME; C57BL MOUSE; CELL PROLIFERATION; FLOW CYTOMETRY; GENETICS; IMMUNOBLOTTING; IMMUNOLOGY; IMMUNOPRECIPITATION; METABOLISM; MOUSE MUTANT; PHOSPHORYLATION; PHYSIOLOGY; SOUTHERN BLOTTING;

MUS;

ADAPTIVE IMMUNITY; ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; B-LYMPHOCYTES; BLOTTING, SOUTHERN; CELL PROLIFERATION; CHROMOSOMES, ARTIFICIAL, BACTERIAL; DENDRITIC CELLS; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOPRECIPITATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; PHOSPHORYLATION; T-LYMPHOCYTES; TYROSINE;

EID: 77952307544     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.09-140806     Document Type: Article

References (29)

1. Flynn, D. C. (2001) Adaptor proteins. Oncogene 20, 6270-6272
2. Pawson, T. (2007) Dynamic control of signaling by modular adaptor proteins. Curr. Opin. Cell Biol. 19, 112-116
3. Claudio, J. O., Zhu, Y. X., Benn, S. J., Shukla, A. H., McGlade, C. J., Falcioni, N., and Stewart, A. K. (2001) HACS1 encodes a novel SH3-SAM adaptor protein differentially expressed in normal and malignant hematopoietic cells. Oncogene 20, 5373-5377
4. Zhu, Y. X., Benn, S., Li, Z. H., Wei, E., Masih-Khan, E., Trieu, Y., Bali, M., McGlade, C. J., Claudio, J. O., and Stewart, A. K. (2004) The SH3-SAM adaptor HACS1 is up-regulated in B cell activation signaling cascades. J. Exp. Med. 200, 737-747
5. Beer, S., Simins, A. B., Schuster, A., and Holzmann, B. (2001) Molecular cloning and characterization of a novel SH3 protein (SLY) preferentially expressed in lymphoid cells. Biochim. Biophys. Acta 1520, 89-93
6. Uchida, T., Nakao, A., Nakano, N., Kuramasu, A., Saito, H., Okumura, K., Ra, C., and Ogawa, H. (2001) Identification of Nash1, a novel protein containing a nuclear localization signal, a sterile alpha motif, and an SH3 domain preferentially expressed in mast cells. Biochem. Biophys. Res. Commun. 288, 137-141
7. Zeller, C., Hinzmann, B., Seitz, S., Prokoph, H., Burkhard-Goettges, E., Fischer, J., Jandrig, B., Schwarz, L. E., Rosenthal, A., and Scherneck, S. (2003) SASH1: a candidate tumor suppressor gene on chromosome 6q24.3 is downregulated in breast cancer. Oncogene 22, 2972-2983
8. Rimkus, C., Martini, M., Friederichs, J., Rosenberg, R., Doll, D., Siewert, J. R., Holzmann, B., and Janssen, K. P. (2006) Prognostic significance of downregulated expression of the candidate tumour suppressor gene SASH1 in colon cancer. Br. J. Cancer 95, 1419-1423
9. Ravetch, J. V., and Lanier, L. L. (2000) Immune inhibitory receptors. Science 290, 84-89
10. Ujike, A., Takeda, K., Nakamura, A., Ebihara, S., Akiyama, K., and Takai, T. (2002) Impaired dendritic cell maturation and increased T(H)2 responses in PIR-B(-/-) mice. Nat. Immunol. 3, 542-548
11. Wang, D., Zhuang, L., Gao, B., Shi, C. X., Cheung, J., Liu, M., Jin, T., and Wen, X. Y. (2008) The Blimp-1 gene regulatory region directs EGFP expression in multiple hematopoietic lineages and testis in mice. Transgenic Res. 17, 193-203
12. Inaba, K., Inaba, M., Romani, N., Aya, H., Deguchi, M., Ikehara, S., Muramatsu, S., and Steinman, R. M. (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J. Exp. Med. 176, 1693-1702
13. Obermaier, B., Dauer, M., Herten, J., Schad, K., Endres, S., and Eigler, A. (2003) Development of a new protocol for 2-day generation of mature dendritic cells from human monocytes. Biol. Proced. Online 5, 197-203
14. Bolland, S., and Ravetch, J. V. (2000) Spontaneous autoimmune disease in FcγRIIB-deficient mice results from strain-specific epistasis. Immunity 13, 277-285
15. Clynes, R., Maizes, J. S., Guinamard, R., Ono, M., Takai, T., and Ravetch, J. V. (1999) Modulation of immune complex-induced inflammation in vivo by the coordinate expression of activation and inhibitory Fc receptors. J. Exp. Med. 189, 179-185
16. O'Keefe, T. L., Williams, G. T., Batista, F. D., and Neuberger, M. S. (1999) Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J. Exp. Med. 189, 1307-1313
17. Beer, S., Scheikl, T., Reis, B., Hüser, N., Pfeffer, K., and Holzmann, B. (2005) Impaired immune responses and prolonged allograft survival in Sly1 mutant mice. Mol. Cell. Biol. 25, 9646-9660
18. Underhill, D. M., and Goodridge, H. S. (2007) The many faces of ITAMs. Trends Immunol. 28, 66-73
19. DeFranco, A. L., Chan, V. M., and Lowell, C. A. (1998) Positive and negative roles of the tyrosine kinase Lyn in B cell function. Semin. Immunol. 10, 299-307
20. Takai, T., and Ono, M. (2001) Activating and inhibitory nature of the murine paired immunoglobulin-like receptor family. Immunol. Rev. 181, 215-222
21. Xu, Y., Harder, K. W., Huntington, N. D., Hibbs, M. L., and Tarlinton, D. M. (2005) Lyn tyrosine kinase: accentuating the positive and the negative. Immunity 22, 9-18
22. Bondada, S., Bikah, G., Robertson, D. A., and Sen, G. (2000) Role of CD5 in growth regulation of B-1 cells. Curr. Top. Microbiol. Immunol. 252, 141-149
23. Sen, G., Bikah, G., Venkataraman, C., and Bondada, S. (1999) Negative regulation of antigen receptor-mediated signaling by constitutive association of CD5 with the SHP-1 protein tyrosine phosphatase in B-1 B cells. Eur. J. Immunol. 29, 3319-3328
24. Fagarasan, S., and Honjo, T. (2000) T-independent immune response: new aspects of B-cell biology. Science 290, 89-92
25. Hibbs, M. L., Tarlinton, D. M., Armes, J., Grail, D., Hodgson, G., Maglitto, R., Stacker, S. A., and Dunn, A. R. (1995) Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease. Cell 83, 301-311
26. O'Keefe, T. L., Williams, G. T., Davies, S. L., and Neuberger, M. S. (1996) Hyperresponsive B cells in CD22-deficient mice. Science 274, 798-801
27. Pan, C., Baumgarth, N., and Parnes, J. R. (1999) CD72-deficient mice reveal nonredundant roles of CD72 in B cell development and activation. Immunity 11, 495-506
28. Pao, L. I., Lam, K. P., Henderson, J. M., Kutok, J. L., Alimzhanov, M., Nitschke, L., Thomas, M. L., Neel, B. G., and Rajewsky, K. (2007) B cell-specific deletion of protein-tyrosine phosphatase Shp1 promotes B-1a cell development and causes systemic autoimmunity. Immunity 27, 35-48
29. -/- mice. Nat. Immunol. 5, 623-629